![]() |
Translational Oncology activity of Kyowa Kirin, Discovery and development of CCR4 monoclonal antibody, mogamulizumabYukimasa Shiotsu, PhD, Kyowa Hakko Kirin California Inc.April 11, 2013Program: Industry/Academia Translational Oncology Symposium 2013 Speakers: Yukimasa Shiotsu Run Time: 18 minutes Yukimasa Shiotsu, PhD, is Director of Translational Oncology for Kyowa Hakko Kirin California. He has more than 15 years experience in oncology... |
For over a decade, TSN has been delivering the stories of science told by the world’s leading thinkers. What are they exploring and why? Why did they become scientists? How do they see science as part of the larger culture? And what lies ahead?
Our new podcast, Talking Science on TSN brings you their conversations with Roger Bingham from the TSN archive and fresh from the bench.
Find the podcast on your favorite podcast app, Soundcloud, iTunes, Stitcher, and RSS.
The Science Network has been available free of charge and without advertising for the past decade.
Gifts from Patrons, Benefactors - and people like you - have made this possible.
As we celebrate TSN@10, we acknowledge past and present donors, including:
SUSTAINING PATRONS
Diane and Rob Zeps
PATRONS
Mary Jane and Robert Engman
BENEFACTORS
The National Science Foundation
The Glenn Foundation
The Dana Foundation
The Kavli Foundation
The ResMed Foundation
The Swartz Foundation
Richard C. Atkinson
Shalom M. Blitz
Peter Farrell
Ernest W. Moody
Jennifer A. Moores
Gerry Ohrstrom
Andrew and Erna Viterbi